| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.001 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |